logo-loader
viewEmerald Health Therapeutics Inc

Emerald Health Therapeutics partners with cannabis researcher VivaCell to boost patent portfolio

The researcher will work with Emerald as it develops medical and recreational cannabis products

Gloved hand holding marijuana in a dish
Emerald Health is a licensed producer authorized by Health Canada to grow, sell and produce cannabis

Cannabis company Emerald Health Therapeutics Inc (CVE:EMH, OTCQX:EMHTF) is looking to strengthen its intellectual property portfolio via a partnership with cannabis-focused research facility VivaCell Biotechnologies.

The institute will work with Emerald Health, evaluating formulas and determining consistent dosages as the company continues to develop medical and recreational cannabis products.

READ: Emerald Health Therapeutics secures long-term supply of hemp for CBD extraction

Emerald Health is a licensed producer authorized by Health Canada to grow, sell and produce cannabis across the country.

“There are a rare few organizations that focus their understanding of the cannabis plant at the heart of its scientific development and strategic operations,” said Emerald CEO Chris Wagner.

The institute partners with academic research centers in Spain like the University of Córdoba, Complutense University of Madrid, Instituto Cajal in Madrid as well as Italy's University of Piemonte Orientale.

The company currently holds 17 patents filed and hopes the data stemming from this partnership will translate into more in the future.

“Our goal is to expand our product pipeline with innovative products substantiated by scientific data and protected by our intellectual property,” added Wagner.

VivaCell is a wholly-owned subsidiary of Emerald Health Sciences, which has a 32% stake in Emerald Health Therapeutics Inc.

Shares of Emerald Health were up slightly to $3.89 by the closing bell Tuesday.

Quick facts: Emerald Health Therapeutics Inc

Price: 0.58 CAD

TSX-V:EMH
Market: TSX-V
Market Cap: $86.68 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Animoca Brands launches Addams Family mobile game and leads investment round...

Animoca Brands Corporation Limited (ASX:AB1) chairman and co-founder Yat Siu updates Proactive on the launch of the official mobile game for Metro Goldwyn Mayer Studios (MGM) film of “The Addams Family”. The chairman also updates the market on entering into a subscription agreement with Sky...

6 hours, 35 minutes ago

2 min read